Spondyloarthritis & psoriatic arthritis

Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis

J RheumatolPublished Cross-sectional study

Authors' conclusion

Many patients with axSpA had impairments in physical performance tests. Importantly, this was frequently seen in tasks requiring coordination and muscle power of the lower extremity. Performance tests provide qualitatively different information than BASFI and BASMI assessments in patients with axSpA.

Study context

Population
Consecutive patients with axial spondyloarthritis (axSpA) (radiographic axSpA 66.5%, nr-axSpA 33.5%; 69% males; mean age 44.3 years)
Participants
200 patients
Exposure
Patients with impairment in ≥ 1 performance test vs patients without impairment
  • Impairedn = 91
Outcome
Impairment of performance tests (inability to perform ≥ 1 performance test) and association between self-reported and performance-based physical functioning
Methodological detailsconsecutive patients, validated cut-offs for impaired physical performance
  • Consecutive patients
  • Validated cut-offs for impaired physical performance

Main finding

As reported in the abstract

Impairment in performance tests

Impairment in ≥ 1 performance test

91 patients

45.5%

Repeated chair stand test impaired (most frequent)

n = 75, 37.5%

Putting on socks impaired (second most frequent)

n = 44, 22%

Observational data: associations, not effects.

Further findings

Characteristics of impaired vs not impaired patients

Age (yrs), impaired vs not impaired
49.1 vs 40.3
BMI (kg/m²), impaired vs not impaired
28.9 vs 25.8
ASDAS, impaired vs not impaired
3.0 vs 2.1
Bath Ankylosing Spondylitis Functional Index (BASFI), impaired vs not impaired
5.8 vs 2.7
Bath Ankylosing Spondylitis Metrology Index (BASMI), impaired vs not impaired
4.4 vs 2.7
ASAS Health Index, impaired vs not impaired
9.5 vs 4.9
PHQ-9 depression screen, impaired vs not impaired
11.6 vs 6.5
  • All P < 0.01

Original publication

Clinically Relevant Deficits in Performance Tests in Patients With Axial Spondyloarthritis. J Rheumatol. Published 1 September 2022. doi:10.3899/jrheum.220239

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.